Mary C. Till and Amanda K. Murphy highlight the USPTO’s request for public comment regarding the experimental use exception. On 28 June 2024, the United States Patent and Trademark Office…
The UK IPO’s refusal of Merck Serono’s SPC application for a new medical indication of cladribine has been upheld but is heading for the Court of Appeal. By Sam Walters…
Alongside SPCs, regulatory exclusivity provides valuable protection for new pharmaceutical products. However, reforms currently in the legislative pipeline will present a significant change from the current practice. By Molly Harte…
A purposive approach to linguistics in the context of claim construction. A way for overcoming a final hurdle to harmonization? By Greg Corcoran, Brenda Holmes, Takahiro Koshibu and Toby Mak….
